Cagrisema is a combination medication for weight management and type 2 diabetes, consisting of two active ingredients:
Cagrilintide – A long-acting amylin analogue (similar to the hormone amylin, which helps regulate appetite and blood sugar).
 – A GLP-1 receptor agonist (which slows gastric emptying, reduces appetite, and improves insulin secretion).
How Does CagriSema Work?
Appetite Suppression – Both drugs act on brain receptors to increase satiety and reduce hunger.
Slowed Gastric Emptying – Delays stomach emptying, making you feel full longer.
Blood Sugar Control – Improves insulin sensitivity and reduces glucagon secretion.
Weight Loss – Combined effects lead to significant reductions in body weight.
Current Research status 
Under investigation in clinical trials (e.g., REDEFINE 1 & 2 for obesity and type 2 diabetes).
 
Research Use Only -